• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向 cruzipain 的药物设计的综合计算方法。

Integrated Computational Approaches for Drug Design Targeting Cruzipain.

机构信息

Department of Electronics and Information Engineering, Jeonbuk National University, Jeonju 54896, Republic of Korea.

Department of Functional Food and Biotechnology, College of Medical Sciences, Jeonju University, Jeonju 55069, Republic of Korea.

出版信息

Int J Mol Sci. 2024 Mar 27;25(7):3747. doi: 10.3390/ijms25073747.

DOI:10.3390/ijms25073747
PMID:38612558
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11011879/
Abstract

Cruzipain inhibitors are required after medications to treat Chagas disease because of the need for safer, more effective treatments. is the source of cruzipain, a crucial cysteine protease that has driven interest in using computational methods to create more effective inhibitors. We employed a 3D-QSAR model, using a dataset of 36 known inhibitors, and a pharmacophore model to identify potential inhibitors for cruzipain. We also built a deep learning model using the Deep purpose library, trained on 204 active compounds, and validated it with a specific test set. During a comprehensive screening of the Drug Bank database of 8533 molecules, pharmacophore and deep learning models identified 1012 and 340 drug-like molecules, respectively. These molecules were further evaluated through molecular docking, followed by induced-fit docking. Ultimately, molecular dynamics simulation was performed for the final potent inhibitors that exhibited strong binding interactions. These results present four novel cruzipain inhibitors that can inhibit the cruzipain protein of .

摘要

克氏锥虫抑制剂在治疗恰加斯病的药物之后是必需的,因为需要更安全、更有效的治疗方法。克氏锥虫是克氏锥虫的来源,克氏锥虫是一种重要的半胱氨酸蛋白酶,这激发了人们使用计算方法来创建更有效的抑制剂的兴趣。我们使用了一个包含 36 种已知抑制剂的数据集和一个药效团模型来建立 3D-QSAR 模型,以鉴定克氏锥虫的潜在抑制剂。我们还使用 Deep purpose 库构建了一个深度学习模型,该模型基于 204 种活性化合物进行训练,并使用特定的测试集进行了验证。在对 Drug Bank 数据库中的 8533 种分子进行全面筛选后,药效团和深度学习模型分别识别出 1012 种和 340 种类药性分子。这些分子进一步通过分子对接进行评估,然后进行诱导契合对接。最终,对表现出强结合相互作用的最终有效抑制剂进行了分子动力学模拟。这些结果提出了四种新型的克氏锥虫抑制剂,可抑制 的克氏锥虫蛋白。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456f/11011879/d43c1d125390/ijms-25-03747-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456f/11011879/c0ccca4972b9/ijms-25-03747-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456f/11011879/5a7e889f2cdb/ijms-25-03747-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456f/11011879/0148220e1fef/ijms-25-03747-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456f/11011879/5953901d23fd/ijms-25-03747-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456f/11011879/b52604866370/ijms-25-03747-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456f/11011879/6cad886b7252/ijms-25-03747-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456f/11011879/a69f30fc6978/ijms-25-03747-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456f/11011879/6b7ade3332b9/ijms-25-03747-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456f/11011879/5a740cced3d4/ijms-25-03747-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456f/11011879/c6571e4b414a/ijms-25-03747-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456f/11011879/d43c1d125390/ijms-25-03747-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456f/11011879/c0ccca4972b9/ijms-25-03747-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456f/11011879/5a7e889f2cdb/ijms-25-03747-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456f/11011879/0148220e1fef/ijms-25-03747-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456f/11011879/5953901d23fd/ijms-25-03747-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456f/11011879/b52604866370/ijms-25-03747-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456f/11011879/6cad886b7252/ijms-25-03747-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456f/11011879/a69f30fc6978/ijms-25-03747-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456f/11011879/6b7ade3332b9/ijms-25-03747-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456f/11011879/5a740cced3d4/ijms-25-03747-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456f/11011879/c6571e4b414a/ijms-25-03747-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/456f/11011879/d43c1d125390/ijms-25-03747-g011.jpg

相似文献

1
Integrated Computational Approaches for Drug Design Targeting Cruzipain.靶向 cruzipain 的药物设计的综合计算方法。
Int J Mol Sci. 2024 Mar 27;25(7):3747. doi: 10.3390/ijms25073747.
2
Identification of natural lead molecules as potential cruzipain inhibitors and decoding the interaction mechanism for the treatment of Chagas disease: a computational biology analysis.鉴定天然先导分子作为潜在的克氏锥虫蛋白酶抑制剂并解析其治疗恰加斯病的相互作用机制:一项计算生物学分析
Nat Prod Res. 2024 Oct;38(20):3676-3680. doi: 10.1080/14786419.2023.2256018. Epub 2023 Sep 7.
3
Structure-Aided Computational Design of Triazole-Based Targeted Covalent Inhibitors of Cruzipain.基于结构的克氏锥虫半胱氨酸蛋白酶靶向共价抑制剂的三唑类化合物的计算设计。
Molecules. 2024 Sep 5;29(17):4224. doi: 10.3390/molecules29174224.
4
Thiosemicarbazone derivatives: Evaluation as cruzipain inhibitors and molecular modeling study of complexes with cruzain.硫代氨基脲衍生物:作为克氏锥虫蛋白酶抑制剂的评价及与克氏锥虫蛋白酶复合物的分子模拟研究
Bioorg Med Chem. 2022 May 1;61:116708. doi: 10.1016/j.bmc.2022.116708. Epub 2022 Mar 16.
5
Novel scaffolds for inhibition of Cruzipain identified from high-throughput screening of anti-kinetoplastid chemical boxes.从抗原生动物化学盒的高通量筛选中鉴定出抑制 Cruzipain 的新型支架。
Sci Rep. 2017 Sep 21;7(1):12073. doi: 10.1038/s41598-017-12170-4.
6
Potent and Selective Inhibitors of Trypanosoma cruzi Triosephosphate Isomerase with Concomitant Inhibition of Cruzipain: Inhibition of Parasite Growth through Multitarget Activity.克氏锥虫磷酸丙糖异构酶的强效选择性抑制剂,同时抑制克氏蛋白酶:通过多靶点活性抑制寄生虫生长
ChemMedChem. 2016 Jun 20;11(12):1328-38. doi: 10.1002/cmdc.201500385. Epub 2015 Oct 23.
7
Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice.克氏锥虫蛋白酶在小鼠体内诱导针对克氏锥虫的黏膜和全身保护作用。
Infect Immun. 2002 Sep;70(9):5065-74. doi: 10.1128/IAI.70.9.5065-5074.2002.
8
The major cysteine proteinase of Trypanosoma cruzi: a valid target for chemotherapy of Chagas disease.克氏锥虫的主要半胱氨酸蛋白酶:恰加斯病化疗的有效靶点。
Curr Pharm Des. 2001 Aug;7(12):1143-56. doi: 10.2174/1381612013397528.
9
Cysteine protease isoforms from Trypanosoma cruzi, cruzipain 2 and cruzain, present different substrate preference and susceptibility to inhibitors.来自克氏锥虫的半胱氨酸蛋白酶同工型,即克氏锥虫蛋白酶2和克氏锥虫蛋白酶,对底物具有不同的偏好性,并且对抑制剂的敏感性也不同。
Mol Biochem Parasitol. 2001 Apr 25;114(1):41-52. doi: 10.1016/s0166-6851(01)00236-5.
10
Structure-based design, optimization of lead, synthesis, and biological evaluation of compounds active against Trypanosoma cruzi.基于结构的设计、先导化合物优化、合成及抗克氏锥虫化合物的生物学评价。
Chem Biol Drug Des. 2023 Oct;102(4):843-856. doi: 10.1111/cbdd.14294. Epub 2023 Jul 16.

本文引用的文献

1
Design and Identification of Inhibitors for the Spike-ACE2 Target of SARS-CoV-2.设计和鉴定针对 SARS-CoV-2 的刺突-ACE2 靶点的抑制剂。
Int J Mol Sci. 2023 May 16;24(10):8814. doi: 10.3390/ijms24108814.
2
Identification of human phosphoglycerate mutase 1 (PGAM1) inhibitors using hybrid virtual screening approaches.使用混合虚拟筛选方法鉴定人磷酸甘油酸变位酶 1(PGAM1)抑制剂。
PeerJ. 2023 Apr 7;11:e14936. doi: 10.7717/peerj.14936. eCollection 2023.
3
Thiosemicarbazone derivatives: Evaluation as cruzipain inhibitors and molecular modeling study of complexes with cruzain.
硫代氨基脲衍生物:作为克氏锥虫蛋白酶抑制剂的评价及与克氏锥虫蛋白酶复合物的分子模拟研究
Bioorg Med Chem. 2022 May 1;61:116708. doi: 10.1016/j.bmc.2022.116708. Epub 2022 Mar 16.
4
Examination of multiple Trypanosoma cruzi targets in a new drug discovery approach for Chagas disease.在一种新的克氏锥虫病药物发现方法中,对多个克氏锥虫靶标进行检查。
Bioorg Med Chem. 2022 Mar 15;58:116577. doi: 10.1016/j.bmc.2021.116577. Epub 2022 Feb 1.
5
Intramolecular Interactions Enhance the Potency of Gallinamide A Analogues against .分子内相互作用增强了加林酰胺A类似物对……的效力。
J Med Chem. 2022 Mar 10;65(5):4255-4269. doi: 10.1021/acs.jmedchem.1c02063. Epub 2022 Feb 21.
6
Infections and Coinfections by Trypanosomatid Parasites in a Rural Community of Venezuela.委内瑞拉农村社区中锥体虫寄生虫的感染和合并感染。
Acta Parasitol. 2022 Jun;67(2):1015-1023. doi: 10.1007/s11686-021-00505-1. Epub 2022 Jan 11.
7
QSAR and deep learning model for virtual screening of potential inhibitors against Inosine 5' Monophosphate dehydrogenase (IMPDH) of Cryptosporidium parvum.用于虚拟筛选微小隐孢子虫肌苷5'-单磷酸脱氢酶(IMPDH)潜在抑制剂的定量构效关系和深度学习模型
J Mol Graph Model. 2022 Mar;111:108108. doi: 10.1016/j.jmgm.2021.108108. Epub 2021 Dec 10.
8
Structure-Based Optimization of Quinazolines as Cruzain and CATL Inhibitors.基于结构的喹唑啉类化合物作为克鲁兹蛋白酶和半胱氨酸蛋白酶L抑制剂的优化
J Med Chem. 2021 Sep 9;64(17):13054-13071. doi: 10.1021/acs.jmedchem.1c01151. Epub 2021 Aug 30.
9
Computer-aided design of 1,4-naphthoquinone-based inhibitors targeting cruzain and rhodesain cysteine proteases.基于 1,4-萘醌的克氏锥虫和罗得西亚锥虫半胱氨酸蛋白酶抑制剂的计算机辅助设计。
Bioorg Med Chem. 2021 Jul 1;41:116213. doi: 10.1016/j.bmc.2021.116213. Epub 2021 May 11.
10
Structure based pharmacophore modeling, virtual screening, molecular docking and ADMET approaches for identification of natural anti-cancer agents targeting XIAP protein.基于结构的药效团模型构建、虚拟筛选、分子对接和 ADMET 方法鉴定靶向 XIAP 蛋白的天然抗癌剂。
Sci Rep. 2021 Feb 18;11(1):4049. doi: 10.1038/s41598-021-83626-x.